Open Label Pharmaco- Magnetic Resonance Spectrography (MRS) Study of Clavulanic Acid
Status:
Completed
Trial end date:
2019-12-20
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to determine how the study drug, clavulanic acid, affects
glutamate in the brain using Magnetic Resonance (MR/MRI) scans. In this study, subjects will
receive the study drug, clavulanic acid and undergo 4 MRI scans. This is being studied to
determine the correct dosing of clavulanic acid, and to gather data so future studies can be
done to find out if this drug is helpful in treating cocaine dependence. Currently, there is
no available medication treatment for cocaine dependence.